Paraneoplastic neurological disorder syndromes

Jan 3, 2021 by in NEUROLOGY Comments Off on Paraneoplastic neurological disorder syndromes

Introduction Paraneoplastic neurological disorder (PND) syndromes are immune-mediated disorders that affect the central, peripheral, or autonomic nervous system in the setting of a cancer. These disorders are not caused by…

read more

Neurologic complications of cancer

Jan 3, 2021 by in NEUROLOGY Comments Off on Neurologic complications of cancer

Introduction to medical complications of brain tumors Patients with brain tumors are at risk of many complications from their cancer. Complications may result from direct effects of the tumor itself…

read more

Approach to the patient with tuberous sclerosis

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the patient with tuberous sclerosis

Introduction Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous condition characterized by a predisposition to hamartomas in the brain, heart, kidney, skin, eye, and other organs. TSC is the…

read more

Approach to the patient with leptomeningeal metastases

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the patient with leptomeningeal metastases

Introduction Leptomeningeal spread occurs in both solid tumors and hematologic malignancies. Leptomeningeal disease (LMD) for all primary cancer types portends a very poor prognosis, with survival measured in weeks if…

read more

Approach to a patient with brain metastasis

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to a patient with brain metastasis

Introduction Brain metastases are a frequent occurrence in patients with solid malignancies. Up to 40% of patients with solid tumors will develop brain metastases at some point in their disease…

read more

Approach to the patient with CNS lymphoma

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the patient with CNS lymphoma

Introduction Primary central nervous system lymphoma (PCNSL) is defined as lymphoma confined to the central nervous system (CNS) at presentation. By contrast, secondary CNS lymphoma represents a systemic lymphoma (i.e.,…

read more

Approach to the high-grade glioma patient

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the high-grade glioma patient

Introduction The broad definition of high-grade glioma encompasses all central nervous system neoplasms that are derived from glial components of the brain and show anaplasia (i.e., poor cellular differentiation, atypia,…

read more

Approach to the low-grade glioma patient

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the low-grade glioma patient

Introduction The understanding of low-grade gliomas has significantly changed over the past 10 years. Genomic and epigenetic discoveries have revolutionized our understanding of these cancers. For the first time, the…

read more

Approach to the meningioma patient

Jan 3, 2021 by in NEUROLOGY Comments Off on Approach to the meningioma patient

Introduction Meningiomas are slow-growing extraaxial tumors that account for about 25% of all intracranial tumors. The World Health Organization (WHO) classifies meningiomas as grade I, II, or III based upon…

read more
Get Clinical Tree app for offline access